Literature DB >> 7572080

Reversibility of neurofilamentous inclusion formation following repeated sublethal intracisternal inoculums of AlCl3 in New Zealand white rabbits.

M J Strong1, S Gaytan-Garcia, D M Jakowec.   

Abstract

In this report, we describe the clinical, topographical and immunohistochemical characteristics of neurofilament (NF) inclusion formation induced by the intracisternal inoculation of young adult New Zealand white rabbits at 28-day intervals with 100 micrograms AlCl3 over the course of 267 days. The ability to recover following cessation of aluminum exposure has also been assessed. The extent of neurofilamentous inclusion formation was proportionate to the cumulative amount of AlCl3 inoculated and initially consisted of fusiform axonal distention in the ventral spinal cord at day 51 following the initial inoculum. Spinal motor neuron perikaryal inclusions and discrete axonal spheroids were observed at day 107 and supraspinal neurofilamentous pathology by day 156. Perikaryal inclusions were immunoreactive to antibodies recognizing both poorly phosphorylated (SMI 32) and more highly phosphorylated high molecular weight NF (NFH). In contrast, axonal spheroids were intensely immunoreactive at all stages with antibodies recognizing highly phosphorylated NFH and an age-dependent NFH phosphorylation state (SMI 34) with only faint SMI 32 immunoreactivity. Immunoreactivity to an antibody recognizing ubiquitin-protein conjugates did not appear until day 156, whereas inclusions were not immunoreactive to antibodies recognizing either phosphatase-dependent or -independent microtubule-associated protein tau at any stage. Upon withdrawal from further AlCl3 exposure after intervals of 51, 107 or 156 days following the initial inoculum, clinical recovery ensued in all rabbits. In all but the most severely affected rabbits, perikaryal neurofilamentous inclusions resolved. However, axonal spheroids continued to be prominent. These studies demonstrate that the repetitive intracisternal inoculation of AlCl3 in New Zealand white rabbits induces a reversible process of neurofilamentous inclusion formation that preferentially affects motor neurons, and in which recovery will occur in those inclusions containing an admixture of both poorly and highly phosphorylated NFH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572080     DOI: 10.1007/BF00294460

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  44 in total

1.  Ubiquitin-immunoreactive filamentous inclusions in anterior horn cells of Guamanian and non-Guamanian amyotrophic lateral sclerosis.

Authors:  S Matsumoto; A Hirano; S Goto
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Soluble, phosphorylated forms of the high molecular weight neurofilament protein in perikarya of cultured neuronal cells.

Authors:  T B Shea; R E Majocha; C A Marotta; R A Nixon
Journal:  Neurosci Lett       Date:  1988-10-17       Impact factor: 3.046

3.  Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study.

Authors:  P N Leigh; A Dodson; M Swash; J P Brion; B H Anderton
Journal:  Brain       Date:  1989-04       Impact factor: 13.501

4.  Neurofibrillary spheroids induced by aluminum phosphate in dorsal root ganglia neurons in vitro.

Authors:  F J Seil; P W Lampert; I Klatzo
Journal:  J Neuropathol Exp Neurol       Date:  1969-01       Impact factor: 3.685

5.  Topography and dynamics of neurofibrillar degeneration in aluminum encephalopathy.

Authors:  H Wiśniewski; O Narkiewicz; K Wiśniewska
Journal:  Acta Neuropathol       Date:  1967-10-20       Impact factor: 17.088

6.  Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules.

Authors:  S Hisanaga; M Kusubata; E Okumura; T Kishimoto
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

7.  Dephosphorylation of microtubule-binding sites at the neurofilament-H tail domain by alkaline, acid, and protein phosphatases.

Authors:  S Hisanaga; S Yasugawa; T Yamakawa; E Miyamoto; M Ikebe; M Uchiyama; T Kishimoto
Journal:  J Biochem       Date:  1993-06       Impact factor: 3.387

8.  200 kDa and 160 kDa neurofilament protein phosphatase resistance following in vivo aluminum chloride exposure.

Authors:  M J Strong; D M Jakowec
Journal:  Neurotoxicology       Date:  1994       Impact factor: 4.294

9.  Intranuclear aluminum accumulation in chronic animals with experimental neurofibrillary changes.

Authors:  E Uemura
Journal:  Exp Neurol       Date:  1984-07       Impact factor: 5.330

10.  Ubiquitin and neurofilament expression in anterior horn cells in amyotrophic lateral sclerosis: possible clues to the pathogenesis.

Authors:  A Migheli; A Attanasio; D Schiffer
Journal:  Neuropathol Appl Neurobiol       Date:  1994-06       Impact factor: 8.090

View more
  2 in total

Review 1.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

2.  Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice.

Authors:  Xiaoguang Li; Zhihao Wang; Lu Tan; Yali Wang; Chengbiao Lu; Rongxiang Chen; Shujuan Zhang; Yuan Gao; Yanchao Liu; Yaling Yin; Xinghua Liu; Enjie Liu; Ying Yang; Yu Hu; Zhipeng Xu; Fuqiang Xu; Jie Wang; Gong-Ping Liu; Jian-Zhi Wang
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.